Drugs Made In America Acquisition (DMIIR) Net Cash Flow (2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Net Cash Flow came in at -$314864.0 in Q4 2025.
Drugs Made In America Acquisition (DMIIR) Net Cash Flow (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 1 years of Net Cash Flow data on file, last reported at -$314864.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 378,972.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | -16.06 Mn |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | -369,667.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | -32,793.00 |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | -72,157.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | -147,921.00 |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | -207,911.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | -133,997.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 328,760.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | -314,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |